Types and Rates of Major Adverse Cardiovascular Events in Antithrombotic Trials: A Systematic Review and Meta-Analysis

Major adverse cardiovascular events (MACE) are common composite end points in trials of antithrombotic therapies, yet their definitions and component event rates may vary between cardiovascular disease and stroke populations. We compared definitions and annualized rates of MACE components, bleeding...

Full description

Bibliographic Details

Published in:	Canadian journal of cardiology
Main Authors:	Wang, Yundi, Fuerte-Hortigon, Alejandro, Chetty, Sarvani, Garah, Mays, Sarmiento, Robert, Barber, Philip A., Saposnik, Gustavo, Lee, Douglas S., Singnurkar, Amit, Swartz, Richard H., Varickanickal, Joann, Field, Thalia S.
Format:	Journal Article
Language:	English
Published:	England Elsevier Inc 25.10.2025
Subjects:	antithrombotics Cardiovascular major adverse cardiovascular events prevention stroke major adverse cardiovascular events cardiovascular stroke prevention antithrombotics
ISSN:	0828-282X, 1916-7075, 1916-7075
Online Access:	Get full text
Tags:	Add Tag No Tags, Be the first to tag this record!